These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 23250713
1. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome. Caletti MG, Balestracci A, Missoni M, Vezzani C. Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713 [Abstract] [Full Text] [Related]
2. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome. Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C. Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876 [Abstract] [Full Text] [Related]
3. Losartan and enalapril are comparable in reducing proteinuria in children. Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C. Kidney Int; 2012 Oct; 82(7):819-26. PubMed ID: 22739977 [Abstract] [Full Text] [Related]
4. Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy. Caletti MG, Missoni M, Vezzani C, Grignoli M, Piantanida JJ, Repetto HA, Exeni R, Rasse SM. Pediatr Nephrol; 2011 Aug; 26(8):1247-54. PubMed ID: 21533629 [Abstract] [Full Text] [Related]
5. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM. Am J Kidney Dis; 2001 Jul; 38(1):18-25. PubMed ID: 11431176 [Abstract] [Full Text] [Related]
6. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors. Seeman T, Pohl M, Misselwitz J, John U. Kidney Blood Press Res; 2009 Jul; 32(6):440-4. PubMed ID: 20016211 [Abstract] [Full Text] [Related]
7. Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome. Van Dyck M, Proesmans W. Pediatr Nephrol; 2004 Jun; 19(6):688-90. PubMed ID: 15064939 [Abstract] [Full Text] [Related]
8. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis. Renke M, Tylicki L, Rutkowski P, Rutkowski B. Scand J Urol Nephrol; 2004 Jun; 38(5):427-33. PubMed ID: 15764256 [Abstract] [Full Text] [Related]
9. Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes. Cetinkaya R, Odabas AR, Selcuk Y. Int J Clin Pract; 2004 May; 58(5):432-5. PubMed ID: 15206496 [Abstract] [Full Text] [Related]
10. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation. Tylicki L, Rutkowski P, Renke M, Rutkowski B. Am J Nephrol; 2002 May; 22(4):356-62. PubMed ID: 12169868 [Abstract] [Full Text] [Related]
11. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z. Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045 [Abstract] [Full Text] [Related]
12. Angiotensin blockade as sole treatment for proteinuric kidney disease in children. Chandar J, Abitbol C, Montané B, Zilleruelo G. Nephrol Dial Transplant; 2007 May; 22(5):1332-7. PubMed ID: 17299000 [Abstract] [Full Text] [Related]
13. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients. Sakallı H, Baskın E, Bayrakcı US, Moray G, Haberal M. Exp Clin Transplant; 2014 Aug; 12(4):310-3. PubMed ID: 24447308 [Abstract] [Full Text] [Related]
14. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis. Tylicki L, Renke M, Rutkowski P, Rutkowski B, Lysiak-Szydłowska W. Med Sci Monit; 2005 Apr; 11(4):PI31-7. PubMed ID: 15795705 [Abstract] [Full Text] [Related]
15. Combined use of enalapril and losartan to reduce proteinuria: a question of safety. Ellis D. Am J Kidney Dis; 2002 Jan; 39(1):209-11. PubMed ID: 11774126 [No Abstract] [Full Text] [Related]
16. [The additive antiproteinuric effect of Enalapril and Losartan to normotensive patients with pathology proteinuria]. Liern M, Dieguez SM, De Reyes V, Vallejos G, Canepa C. Nefrologia; 2004 Jan; 24(6):553-8. PubMed ID: 15683027 [Abstract] [Full Text] [Related]
17. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S. Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837 [Abstract] [Full Text] [Related]
18. Renal and retinal effects of enalapril and losartan in type 1 diabetes. Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R. N Engl J Med; 2009 Jul 02; 361(1):40-51. PubMed ID: 19571282 [Abstract] [Full Text] [Related]
19. Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D). Fried LF, Duckworth W, Zhang JH, O'Connor T, Brophy M, Emanuele N, Huang GD, McCullough PA, Palevsky PM, Seliger S, Warren SR, Peduzzi P, VA NEPHRON-D Investigators. Clin J Am Soc Nephrol; 2009 Feb 02; 4(2):361-8. PubMed ID: 19118120 [Abstract] [Full Text] [Related]
20. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome. Liern M, Colazo A, Vallejo G, Zotta E. Nefrologia (Engl Ed); 2021 Feb 02; 41(3):304-310. PubMed ID: 36166246 [Abstract] [Full Text] [Related] Page: [Next] [New Search]